To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.

NCT05925452 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
221
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.